Summary tables comparing neoplastic disorders: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:navy;" |'''κ/λ''' | |colspan="1" style = "font-size:90%; color:navy;" |'''κ/λ''' | ||
|colspan="1" style = "background:#00b8e6;"| | |colspan="1" style = "background:#00b8e6;"|40:60% (wk) | ||
|colspan="1" style = "width: 8%; background:#004466;"| | |colspan="1" style = "width: 8%; background:#004466;"| | ||
|colspan="1" style = "width: 8%; background:#006699;"| | |colspan="1" style = "width: 8%; background:#006699;"| |
Revision as of 17:26, 21 June 2023
Immunophenotype LPD | |||
---|---|---|---|
Marker | CLL | MCL | FL |
κ/λ | 40:60% (wk) | ||
FMC7 | |||
CD5 | |||
CD10 | |||
CD11C | |||
CD19 | |||
CD20 | |||
CD23 | |||
CD25 | wk | ||
CD38 | |||
CD43 | |||
CD79a | wk | ||
CD103 | |||
CD138 | |||
CD200 |
Key to table:
Key to colour code Click for link
Key to expression code Click for link